Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- CMIC Holdings, UDG Healthcare Collaborate in CSO, CMO Businesses
November 13, 2014
- Avigan Could Clinch Overseas Approval for Ebola Early Next Year: Fujifilm Official
November 13, 2014
- Fujifilm Sees Healthcare as Growth Engine in Next 3 Years, yet No New Drug Debut until FY2018
November 12, 2014
- Generic Makers Back on Growth Track in First Half of FY2014
November 12, 2014
- Shionogi Lodges Complaint against Tax Reassessment over ViiV Deal
November 12, 2014
- Daiichi Sankyo Completes Tender Offer to Acquire Ambit Biosciences
November 12, 2014
- Takeda, GE Healthcare Forge Alliance for Hepatic Diseases
November 12, 2014
- Ethical Drug Sales Down 0.2% in September Owing to Long-Listed Drug Sales Decline: Crecon Report
November 12, 2014
- BIKEN Begins Clinical Trial of Varicella Vaccine for Herpes Zoster
November 12, 2014
- Dermatology Firm Maruho Eyes US Product Rollout in Next 3 Years
November 12, 2014
- Santen Extending Geographic Reach in Europe after Merck Asset Transfer
November 11, 2014
- Kowa Looks to Triple Eye Drug Business with Glanatec
November 11, 2014
- Germany Designates Eisai’s Antiepileptic Drug Fycompa as Reference Price Drug
November 11, 2014
- AstraZeneca Taps Foreign Doctors to Speak on Forxiga Use Abroad
November 11, 2014
- Nichi-Iko Aims for 300 Million Yen Second Half Sales for Generics Launched in December
November 10, 2014
- Takeda Files Suit in US Claiming Infringement of Its Patents for Gout Treatment Colcrys
November 10, 2014
- MTPC, J&J Collaborate to Promote Educational Activities for Diabetes
November 10, 2014
- Feburic Grabs Top Slot for GP Market in September “Mind Share” Ranking
November 10, 2014
- Meiji Seika Pharma Poised to Get Lion’s Share in Antidepressant Market
November 10, 2014
- Bayer, Kyoto Univ. to Hold First Collaborative Meeting by March
November 7, 2014
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…